Cargando…

Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy

BACKGROUND: There is no consistent evidence about the appropriate treatment strategies for gastric signet ring cell carcinoma (GSRC) to improve prognosis. We conducted a population‐based study to examine the effects of combined modality therapies on survival outcomes using the Surveillance, Epidemio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yang, Zhu, Zhikai, Ma, Fuhai, Xue, Liyan, Tian, Yantao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520351/ https://www.ncbi.nlm.nih.gov/pubmed/32744431 http://dx.doi.org/10.1002/cam4.3342

Ejemplares similares

Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges
por: Li, Yang, et al.
Publicado: (2020)

Prognostic Significance of Signet Ring Cells in Gastric Cancer: The Higher Proportion, The Better Survival
por: Li, Yang, et al.
Publicado: (2021)

The value of adjuvant chemotherapy in stage II/III colorectal signet ring cell carcinoma
por: Zhao, Zhuang, et al.
Publicado: (2020)

Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Li, Chao, et al.
Publicado: (2022)

Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer
por: Zhu, Yue-Ting, et al.
Publicado: (2020)

Retracted: Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer
por: Ma, Gui-Fen, et al.
Publicado: (2019)

Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study
por: Shi, Tao, et al.
Publicado: (2019)

D2‐resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy
por: Peng, Jin, et al.
Publicado: (2016)

Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
por: Shi, Jinming, et al.
Publicado: (2022)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer
por: Wang, Yizhuo, et al.
Publicado: (2016)

Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing
por: Li, Guoliang, et al.
Publicado: (2022)

The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
por: Lv, Hao, et al.
Publicado: (2021)

Individualised adjuvant immunotherapy with neoantigen‐reactive T cells for gastric signet‐ring cell carcinoma
por: Ding, Naiqing, et al.
Publicado: (2023)

Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component
por: Zhu, Ziyu, et al.
Publicado: (2020)

The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy
por: Jiang, Huici, et al.
Publicado: (2021)

Differences in clinicopathological characteristics and computed tomography findings between signet ring cell carcinoma and nonsignet ring cell carcinoma in early and advanced gastric cancer
por: Chen, Jian, et al.
Publicado: (2018)

Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study
por: Lam, Robert, et al.
Publicado: (2022)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Gastric metastasis of mammary signet ring cell carcinoma--a differential diagnosis with primary gastric signet ring cell carcinoma.
por: Yim, H., et al.
Publicado: (1997)

Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study
por: Alradhi, Mohammed, et al.
Publicado: (2022)

Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis
por: Shi, Tao, et al.
Publicado: (2019)

Clinicopathological characteristics and prognosis of gastric signet ring cell carcinoma
por: Tian, Hua-Kai, et al.
Publicado: (2022)

Rectal Signet Ring Cell Carcinoma: Post-Chemoradiotherapy Evaluation by MRI and Corresponding to Pathology
por: Zhou, Yin, et al.
Publicado: (2022)

Prognostic Significance of Signet-Ring Cell Components in Patients With Gastric Carcinoma of Different Stages
por: Dong, Xiaoyuan, et al.
Publicado: (2021)

Primary Gastric Signet Ring Cell Carcinoma or Metastatic Lobular Carcinoma With Signet Ring Cells: A Diagnostic Challenge
por: Akouh, Nada, et al.
Publicado: (2023)

Bladder metastasis of gastric signet-ring cell carcinoma
por: Kazaz, İlke Onur, et al.
Publicado: (2018)

Signet Ring Early Gastric Cancer: Seize the Opportunity
por: Bechara, Robert, et al.
Publicado: (2020)

The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma
por: Li, Xiangpan, et al.
Publicado: (2022)

Difference Between Signet Ring Cell Gastric Cancers and Non-Signet Ring Cell Gastric Cancers: A Systematic Review and Meta-Analysis
por: Zhang, Chi, et al.
Publicado: (2021)

NK cells adjuvant therapy shows survival benefits in a gastric mixed signet ring cell carcinoma patient: A case report
por: Jin, Yuan-Yuan, et al.
Publicado: (2021)

Massive gastric distension due to signet-ring cell gastric adenocarcinoma
por: Zakaria, Ali, et al.
Publicado: (2020)

Adenosquamous carcinoma may have an inferior prognosis to signet ring cell carcinoma in patients with stages I and II gastric cancer
por: Chu, Yu-Xin, et al.
Publicado: (2020)

Effects of Tumor Localization, Age, and Stage on the Outcomes of Gastric and Colorectal Signet Ring Cell Adenocarcinomas
por: Benesch, Matthew G. K., et al.
Publicado: (2023)

Prognostic Performance of Three Lymph-Node Staging Systems on Gastric Signet-Ring-Cell Carcinoma
por: Zhang, Limin, et al.
Publicado: (2023)

The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer
por: Kim, Seong-Geun, et al.
Publicado: (2016)

Breast Metastatic Localization of Signet-Ring Cell Gastric Carcinoma
por: Parrell Soler, C., et al.
Publicado: (2011)

TAZ Is Highly Expressed in Gastric Signet Ring Cell Carcinoma
por: Yue, Guofeng, et al.
Publicado: (2014)

Pericardial Biopsy Revealed Gastric Signet-Ring Cell Cancer
por: Hashimoto, Yu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bf3g8te9s1lc043f3hlaa2qu1h